Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant human growth hormone fused to alpha1-antitrypsin variant |
|---|---|
| Date Designated: | 12/19/2019 |
| Orphan Designation: | Treatment of Growth Hormone Deficiency |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Alteogen, Inc. 62 Yuseong-daero 1628 beon-gil Yuseong-gu Daejeon, Daejeon South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







